BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+0.22%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
AUM
$116M
AUM Growth
Cap. Flow
+$116M
Cap. Flow %
100%
Top 10 Hldgs %
96.08%
Holding
15
New
15
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 96.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$63.9M 55.2% +2,023,232 New +$63.9M
NGNE icon
2
Neurogene
NGNE
$264M
$10.1M 8.72% +809,415 New +$10.1M
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$8.26M 7.13% +313,626 New +$8.26M
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
$7.18M 6.2% +160,000 New +$7.18M
KURA icon
5
Kura Oncology
KURA
$686M
$5.5M 4.75% +654,595 New +$5.5M
VTAE
6
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$4.53M 3.91% +250,270 New +$4.53M
ARDM
7
DELISTED
Aradigm Corp Common Stock
ARDM
$4.37M 3.78% +1,101,513 New +$4.37M
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
$3.32M 2.86% +225,000 New +$3.32M
EIGR
9
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.06M 1.78% +1,399,991 New +$2.06M
AKTX
10
Akari Therapeutics
AKTX
$24.8M
$2.03M 1.75% +139,899 New +$2.03M
SPHS
11
DELISTED
Sophiris Bio, Inc.
SPHS
$1.78M 1.54% +1,000,000 New +$1.78M
NBRV
12
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.69M 1.46% +176,710 New +$1.69M
NVET
13
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$528K 0.46% +154,840 New +$528K
ALDX icon
14
Aldeyra Therapeutics
ALDX
$351M
$428K 0.37% +63,146 New +$428K
EPIX icon
15
ESSA Pharma
EPIX
$11.4M
$119K 0.1% +28,100 New +$119K